2 doses for a primary series and 1 dose as a booster, except the Omicron XBB.1.5 subvariant vaccine. Omicron XBB.1.5 subvariant vaccine doses: The Moderna Spikevax ® Bivalent COVID-19 vaccine ...

The rivalry between Moderna and Pfizer/BioNTech in commercialising ... but are "surprised by the litigation given the COVID-19 vaccine was based on BioNTech's proprietary mRNA technology and ...

The Centers for Disease Control and Prevention's (CDC’s) vaccine advisory committee will meet on Tuesday for a two-day session to lay out new recommendations, including a proposal to scale back ...

Unlike countries such as the United Kingdom, Canada and Australia, the US alone recommends an annual Covid-19 vaccine for healthy younger adults and children. The World Health Organization also ...

multisystem inflammatory syndrome and COVID-19 vaccine uptake, the agency said. Outside medical groups have opposed scaling back recommendations for COVID-19 vaccines, citing concerns that the ...

Moderna says it has become the first company in the pharma sector with phase 3 data on a combined vaccine for both COVID-19 and influenza and will soon be ready to discuss “next steps” with ...

The program will run until June 30. An additional dose will be available to people who received a dose of a COVID-19 vaccine since fall 2024, provided it has been at least three months since that ...

Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula targeting the JN.1 strain resulted in fewer and less ...

As of April 5, less than a quarter of adults in the U.S. have gotten an updated COVID-19 vaccine. Millions worldwide have had long COVID-19, with dozens of widely varying symptoms, including ...